Didier Pruneau

2.2k total citations
80 papers, 1.8k citations indexed

About

Didier Pruneau is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Didier Pruneau has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 38 papers in Molecular Biology and 20 papers in Hematology. Recurrent topics in Didier Pruneau's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Receptor Mechanisms and Signaling (11 papers). Didier Pruneau is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Receptor Mechanisms and Signaling (11 papers). Didier Pruneau collaborates with scholars based in France, United States and Germany. Didier Pruneau's co-authors include Pierre Bélichard, James A. Angus, Nikolaus Plesnila, Jean‐Luc Paquet, Claude Robert, A. Baethmann, Pierre Dodey, Evelyne Defrêne, Jean‐Michel Luccarini and Michel Plotkine and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Analytical Biochemistry.

In The Last Decade

Didier Pruneau

79 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Didier Pruneau France	25	781	734	361	336	244	80	1.8k
Chun‐Fang Xia United States	18	271 0.3×	611 0.8×	91 0.3×	248 0.7×	123 0.5×	27	1.7k
Marc W. Nolte Germany	19	490 0.6×	264 0.4×	422 1.2×	140 0.4×	142 0.6×	33	1.2k
Ursula Quitterer Germany	30	468 0.6×	2.1k 2.8×	177 0.5×	899 2.7×	893 3.7×	55	3.3k
Daniel Palmer United States	19	127 0.2×	1.4k 2.0×	225 0.6×	341 1.0×	359 1.5×	27	2.1k
Akio Hirata Japan	27	190 0.2×	664 0.9×	241 0.7×	356 1.1×	919 3.8×	105	2.7k
Margitta Elvers Germany	27	179 0.2×	689 0.9×	797 2.2×	135 0.4×	459 1.9×	67	2.4k
Francis Rioux Canada	30	393 0.5×	1.8k 2.5×	155 0.4×	1.8k 5.2×	337 1.4×	114	2.8k
Jun Agata Japan	19	327 0.4×	455 0.6×	94 0.3×	194 0.6×	377 1.5×	26	1.3k
Zheng G. Zhang United States	23	189 0.2×	941 1.3×	49 0.1×	389 1.2×	63 0.3×	38	2.4k
Said AbdAlla Germany	21	286 0.4×	1.2k 1.6×	98 0.3×	588 1.8×	776 3.2×	25	2.1k

Countries citing papers authored by Didier Pruneau

Since Specialization

Citations

This map shows the geographic impact of Didier Pruneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Pruneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Pruneau more than expected).

Fields of papers citing papers by Didier Pruneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Pruneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Pruneau. The network helps show where Didier Pruneau may publish in the future.

Co-authorship network of co-authors of Didier Pruneau

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Pruneau. A scholar is included among the top collaborators of Didier Pruneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Pruneau. Didier Pruneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caplette, Romain, Élisabeth Dubus, Grégory Gauvain, et al.. (2016). Optogenetic visual restoration using ChrimsonR: Validation in degenerative rodent models, rd1 and P23H.. Investigative Ophthalmology & Visual Science. 57(12). 600–600. 2 indexed citations

Thomasson, Nitza, Hélène Cwerman‐Thibault, Sébastien Augustin, et al.. (2014). Safety, local tolerability and biodistribution of GS010 (AAV2/2-ND4), a gene therapy medicinal product in development for Leber Hereditary Optic Neuropathy (LHON). Investigative Ophthalmology & Visual Science. 55(13). 3340–3340. 1 indexed citations

Catusse, Julie, et al.. (2003). Cloning and characterization of guinea pig interleukin-8 receptor. Biochemical Pharmacology. 66(7). 1171–1180. 10 indexed citations

Li, Dingzhou, Isabelle Margaill, Bruno Palmier, et al.. (2003). LF 16‐0687 Ms, a bradykinin B₂ receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. British Journal of Pharmacology. 139(8). 1539–1547. 47 indexed citations

Zausinger, Stefan, David B. Lumenta, Didier Pruneau, et al.. (2002). Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Research. 950(1-2). 268–278. 64 indexed citations

Rachinsky, Maxim, et al.. (2001). The Importance of Kinin Antagonist Treatment Timing in Closed Head Trauma. The Journal of Trauma: Injury, Infection, and Critical Care. 51(5). 944–948. 5 indexed citations

Schulz, Joachim, Nikolaus Plesnila, J. Eriskat, et al.. (2000). LF16-0687 A Novel Non-Peptide Bradykinin B2 Receptor Antagonist Reduces Vasogenic Brain Edema from a Focal Lesion in Rats. PubMed. 76. 137–139. 20 indexed citations

Pruneau, Didier, et al.. (2000). Identification of a Key Region of Kinin B1 Receptor for High Affinity Binding of Peptide Antagonists. Journal of Biological Chemistry. 275(9). 6107–6113. 15 indexed citations

Marie, Jacky, Didier Pruneau, Jean‐Luc Paquet, et al.. (1999). Constitutive Activation of the Human Bradykinin B₂Receptor Induced by Mutations in Transmembrane Helices III and VI. Molecular Pharmacology. 55(1). 92–101. 53 indexed citations

10.

Pruneau, Didier, Jean‐Michel Luccarini, Evelyne Defrêne, et al.. (1999). In vitro and in vivo effects of the new nonpeptide bradykinin B₂receptor antagonist, LF 16‐0335C, on guinea‐pig and rat kinin receptors. Fundamental and Clinical Pharmacology. 13(1). 75–83. 8 indexed citations

11.

Pruneau, Didier, et al.. (1999). Effect of LF 16-0687MS, a New Nonpeptide Bradykinin B ₂ Receptor Antagonist, in a Rat Model of Closed Head Trauma. Journal of Neurotrauma. 16(11). 1057–1065. 38 indexed citations

12.

Pruneau, Didier, Jean‐Michel Luccarini, Evelyne Defrêne, et al.. (1998). LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B₂ receptor. British Journal of Pharmacology. 125(2). 365–372. 22 indexed citations

13.

Pruneau, Didier, et al.. (1997). Stable expression of human kinin B₁ receptor in 293 cells: pharmacological and functional characterization. British Journal of Pharmacology. 122(2). 393–399. 36 indexed citations

14.

Pruneau, Didier, Jean‐Michel Luccarini, Evelyne Defrêne, Jean‐Luc Paquet, & Pierre Bélichard. (1996). Characterisation of bradykinin receptors from juvenile pig coronary artery. European Journal of Pharmacology. 297(1-2). 53–60. 21 indexed citations

15.

Bélichard, Pierre, et al.. (1996). Haemodynamic and cardiac effects of kinin B₁ and B₂ receptor stimulation in conscious instrumented dogs. British Journal of Pharmacology. 117(7). 1565–1571. 25 indexed citations

16.

Nouet, Sandrine, Pierre Dodey, Patrice Renaut, et al.. (1994). Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.. Molecular Pharmacology. 46(4). 693–701. 5 indexed citations

17.

Pruneau, Didier & Pierre Bélichard. (1992). Haemodynamic and humoral effects of ω-conotoxin GVIA in normotensive and spontaneously hypertensive rats. European Journal of Pharmacology. 211(3). 329–335. 19 indexed citations

18.

Bélichard, Pierre, Didier Pruneau, René Rouet, & J L Salzmann. (1991). Electrophysiological Responses of Hypertrophied Rat Myocardium to Combined Hypoxia, Hyperkalemia, and Acidosis. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S141–S145. 19 indexed citations

19.

Pruneau, Didier, et al.. (1990). Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action. Fundamental and Clinical Pharmacology. 4(2). 223–243. 1 indexed citations

20.

Bélichard, Pierre, Didier Pruneau, & Luc Rochette. (1988). Influence of spontaneous hypertension and cardiac hypertrophy on the severity of ischemic arrhythmias in the rat. Basic Research in Cardiology. 83(5). 560–566. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact